Martin Wernli
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Genetics top 2%
- Pathology and Forensic Medicine top 5%
- Hematology top 5%
- Co-authors
- David SchwappachRoger StuppDaniel BetticherHanspeter HoneggerArnaud RothThomas CernyMarkus BornerRolf A. Stahel
- Topics
- Chronic Lymphocytic Leukemia Research (7 papers)Lung Cancer Treatments and Mutations (7 papers)Lymphoma Diagnosis and Treatment (7 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Martin Wernli
47 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 100
- Pulmonary and Respiratory Medicine 953
- Oncology 840
- Genetics 403
- Pathology and Forensic Medicine 403
- Hematology 249
Countries citing papers authored by Martin Wernli
This map shows the geographic impact of Martin Wernli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wernli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wernli more than expected).
Fields of papers citing papers by Martin Wernli
This network shows the impact of papers produced by Martin Wernli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wernli. The network helps show where Martin Wernli may publish in the future.
Co-authorship network of co-authors of Martin Wernli
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Wernli. A scholar is included among the top collaborators of Martin Wernli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Wernli. Martin Wernli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 48 | |
| 2 | 48 | |
| 3 | 27 | |
| 4 | 2 | |
| 5 | 98 | |
| 6 | 8 | |
| 7 | 121 | |
| 8 | 87 | |
| 9 | 29 | |
| 10 | 16 | |
| 11 | 32 | |
| 12 | 37 | |
| 13 | 25 | |
| 14 | 106 | |
| 15 | 6 | |
| 16 | 24 | |
| 17 | 103 | |
| 18 | 5 | |
| 19 | 35 | |
| 20 | 14 |
About Martin Wernli
Martin Wernli is a scholar working on Genetics, Emergency Medical Services and Hematology, having authored 47 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Genetics (403 citations), Oncology (840 citations) and Pulmonary and Respiratory Medicine (953 citations). Martin Wernli has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include David Schwappach, Roger Stupp, Daniel Betticher, Hanspeter Honegger, Arnaud Roth, Thomas Cerny, Markus Borner, Rolf A. Stahel, Piercarlo Saletti and Mario Bargetzi. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.